We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


InVentis Technologies to Distribute TriLink Products in India

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

TriLink BioTechnologies, Inc. has entered into a distribution agreement with inVentis Technologies, an Indian distribution and manufacturing company specializing in the life science and applied science, research, diagnostics and QC market. The agreement allows inVentis to market TriLink’s complete line of nucleic acid-based products. This includes TriLink’s stocked and custom nucleotides, oligonucleotides and mRNA, as well as their CleanAmp™ Hot Start PCR Products.

"With the biotech industry growing rapidly in India, TriLink has been looking for the right opportunity to enter the market. InVentis provides an extensive line of life science products to the biotech and pharmaceutical market and we feel that our high quality nucleic acid-based products will complement their offering and help advance research in the area,” commented TriLink's President and CEO, Richard Hogrefe, Ph.D. 

 “With the biotechnology industry in India increasingly focused on “OMICS”, InVentis has been looking for a world-class nucleic acid-based product line to fulfill the growing demand in the genomics and molecular biology sector. We anticipate that the market will continue to grow and addition of TriLink products will complement the portfolio offered by InVentis”, stated Founder and BM Singh, Sandeep. “We are delighted to enter into an agreement with TriLink.”